Acorn65 said:
My answer is how can you think he doesn't care about you?
Aside from the non-reporting, he has been building a powerful group of Test Manufacturers, Test Sites and other delivery systems for a large scale QDX HealthID ecosystem. The non-reporting has not stopped the company from growing the ecosystem which seems almost ready to open up with revenue.
Really, as you read the quotes in these PRs, ask yourself why the CEOs of Innova, MedGenDX and Mig USA have become partners of QMC, a non-reporting company? It did not stop them from partnering, did it? The other thing I note is that the quotes are all very similar. All the CEOs and Squires are on the same wavelength, the same commitment.
As shareholders, isn't that caring about you? Building the company? We've all had an extended time to buy in more if we wanted, on the ground floor, so to speak. Say what you want, but Squires has shown consistency in dedication and purpose as CEO in going forward.
Shareholder updates? Every PR is a Shareholder update. They are here:
https://www.quantummaterialscorp.com/news
Below are all the Squires quotes from the last year's PRs.
His caring is shown in his ability to build a group with his vision with seemingly minimal cash and staff, for the benefit of the shareholders.
August 13, 2020 - QDXTM HealthID Signs Distribution Agreement with Innova Medical Group Inc. Adding Antigen, Molecular and Antibody Tests to its COVID-19 Test Ecosystem
"We are excited to be working with Innova Medical Group and adding its test kit portfolio to our QDX™ HealthID ecosystem," says Stephen B. Squires, CEO of QDX HealthID Incorporated. "This ecosystem now offers a comprehensive set of COVID-19 testing options allowing QDX™ HealthID to address the health safety needs of myriad industries and testing environments."
“We are confident that adding QDX HealthID Incorporated to Innova Medical Group’s rapid test kit distribution group will ensure that even more, superior testing solutions will continue being a key solution for effectively detecting and tracking the COVID-19 virus, worldwide,” shares Dr. Charles Huang, Founder and Partner of Pasaca Capital Inc. “As industry leaders specializing in research, development, and the production of point-of-care testing, in-vitro diagnostic devices, and reagents, our test kit developers are all well-known as makers of superior technologies providing better healthcare solutions to benefit people everywhere.”
July 28, 2020 - QDXTM HealthID Expands its COVID-19 Ecosystem with MIG USA Antibody Test Kits and other Contagion Mitigation Products
"We are pleased to expand the ecosystem of test kits and diagnostic services that are part of our QDX™ HealthID service with the inclusion of the MIG USA serology tests," says Stephen B. Squires, CEO of QDX HealthID Incorporated. "These antibody test kits and MIG USA’s products complement those from other ecosystem members and demonstrates the open approach we’ve taken with QDX™ HealthID."
“We are excited to work with QDX™ HealthID to help fulfill our mission to provide COVID-19 testing and tracking to potentially save lives and reopen businesses, and our contagion mitigation products, which are subject to collaboration with QDX HealthID Incorporated, promise to provide a whole host of novel approaches to future epidemics,” says Dr. Adnan Mjalli, CEO and Chairman, MIG USA.
July 15, 2020 - QDXTM HealthID to Support Saliva/Sputum-based COVID-19 Diagnostic Services Developed by MicroGenDX
"We are delighted to be working with MicroGenDX and making its easy-to-administer, FDAauthorized saliva/sputum specimen test available to our QDX TM HealthID customers," says Stephen B. Squires, CEO of QDX HealthID. "Our combined capabilities will allow companies to offer attractive back-to-work programs that give their employees a choice of testing options.”
“MicroGenDX is excited to register its test kits and diagnostic services on the innovative QDXTM HealthID service. MicroGenDX has pioneered the use of saliva/sputum samples for COVID-19 testing, and sputum collection and views the QDX™ Health ID service as a value-add for physicians who prescribe our tests and a convenience for consumers,” notes MicroGenDX CEO Rick Martin.
April 13, 2020 - Quantum Materials Corp Announces QDXTM HealthID to Support Back-to-Work "Immunization Passport" Programs
"QDXTM HealthID supports vital population health and economic rebuilding imperatives," says Stephen B. Squires, President & CEO of QMC. "Not only does this service facilitate improved health outcomes for patients, but it also underpins back-to-work certifications, sometimes referred to as immunization passports." (NOTE: now Health Status Reports)
Additionally, Les Paull, Phd., CEO of QMVT LLC, which is responsible for sales and marketing of QMC’s innovations, states “The world must have a system that eliminates the fears and anxiety of not knowing who is able to return to work."
October 31, 2019 - Quantum Materials Corp to Detail Vision and Provide Information on its Anti-Counterfeit Capabilities and Market Opportunities
“We are delighted to be providing more information about our company’s industry first in combining the capabilities of nanotechnology and blockchain,” said Stephen B. Squires, President and Chief Executive Officer of Quantum Materials Corp. “We look forward to detailing our vision to establish Quantum Materials’ combination of these transformative technologies as a globally deployed universal platform for all product authenticity and supply chain track and trace requirements.”
Quote:Why would you think Squires cares about you or me?
My answer is how can you think he doesn't care about you?
Aside from the non-reporting, he has been building a powerful group of Test Manufacturers, Test Sites and other delivery systems for a large scale QDX HealthID ecosystem. The non-reporting has not stopped the company from growing the ecosystem which seems almost ready to open up with revenue.
Really, as you read the quotes in these PRs, ask yourself why the CEOs of Innova, MedGenDX and Mig USA have become partners of QMC, a non-reporting company? It did not stop them from partnering, did it? The other thing I note is that the quotes are all very similar. All the CEOs and Squires are on the same wavelength, the same commitment.
As shareholders, isn't that caring about you? Building the company? We've all had an extended time to buy in more if we wanted, on the ground floor, so to speak. Say what you want, but Squires has shown consistency in dedication and purpose as CEO in going forward.
Shareholder updates? Every PR is a Shareholder update. They are here:
https://www.quantummaterialscorp.com/news
Below are all the Squires quotes from the last year's PRs.
His caring is shown in his ability to build a group with his vision with seemingly minimal cash and staff, for the benefit of the shareholders.
August 13, 2020 - QDXTM HealthID Signs Distribution Agreement with Innova Medical Group Inc. Adding Antigen, Molecular and Antibody Tests to its COVID-19 Test Ecosystem
"We are excited to be working with Innova Medical Group and adding its test kit portfolio to our QDX™ HealthID ecosystem," says Stephen B. Squires, CEO of QDX HealthID Incorporated. "This ecosystem now offers a comprehensive set of COVID-19 testing options allowing QDX™ HealthID to address the health safety needs of myriad industries and testing environments."
“We are confident that adding QDX HealthID Incorporated to Innova Medical Group’s rapid test kit distribution group will ensure that even more, superior testing solutions will continue being a key solution for effectively detecting and tracking the COVID-19 virus, worldwide,” shares Dr. Charles Huang, Founder and Partner of Pasaca Capital Inc. “As industry leaders specializing in research, development, and the production of point-of-care testing, in-vitro diagnostic devices, and reagents, our test kit developers are all well-known as makers of superior technologies providing better healthcare solutions to benefit people everywhere.”
July 28, 2020 - QDXTM HealthID Expands its COVID-19 Ecosystem with MIG USA Antibody Test Kits and other Contagion Mitigation Products
"We are pleased to expand the ecosystem of test kits and diagnostic services that are part of our QDX™ HealthID service with the inclusion of the MIG USA serology tests," says Stephen B. Squires, CEO of QDX HealthID Incorporated. "These antibody test kits and MIG USA’s products complement those from other ecosystem members and demonstrates the open approach we’ve taken with QDX™ HealthID."
“We are excited to work with QDX™ HealthID to help fulfill our mission to provide COVID-19 testing and tracking to potentially save lives and reopen businesses, and our contagion mitigation products, which are subject to collaboration with QDX HealthID Incorporated, promise to provide a whole host of novel approaches to future epidemics,” says Dr. Adnan Mjalli, CEO and Chairman, MIG USA.
July 15, 2020 - QDXTM HealthID to Support Saliva/Sputum-based COVID-19 Diagnostic Services Developed by MicroGenDX
"We are delighted to be working with MicroGenDX and making its easy-to-administer, FDAauthorized saliva/sputum specimen test available to our QDX TM HealthID customers," says Stephen B. Squires, CEO of QDX HealthID. "Our combined capabilities will allow companies to offer attractive back-to-work programs that give their employees a choice of testing options.”
“MicroGenDX is excited to register its test kits and diagnostic services on the innovative QDXTM HealthID service. MicroGenDX has pioneered the use of saliva/sputum samples for COVID-19 testing, and sputum collection and views the QDX™ Health ID service as a value-add for physicians who prescribe our tests and a convenience for consumers,” notes MicroGenDX CEO Rick Martin.
April 13, 2020 - Quantum Materials Corp Announces QDXTM HealthID to Support Back-to-Work "Immunization Passport" Programs
"QDXTM HealthID supports vital population health and economic rebuilding imperatives," says Stephen B. Squires, President & CEO of QMC. "Not only does this service facilitate improved health outcomes for patients, but it also underpins back-to-work certifications, sometimes referred to as immunization passports." (NOTE: now Health Status Reports)
Additionally, Les Paull, Phd., CEO of QMVT LLC, which is responsible for sales and marketing of QMC’s innovations, states “The world must have a system that eliminates the fears and anxiety of not knowing who is able to return to work."
October 31, 2019 - Quantum Materials Corp to Detail Vision and Provide Information on its Anti-Counterfeit Capabilities and Market Opportunities
“We are delighted to be providing more information about our company’s industry first in combining the capabilities of nanotechnology and blockchain,” said Stephen B. Squires, President and Chief Executive Officer of Quantum Materials Corp. “We look forward to detailing our vision to establish Quantum Materials’ combination of these transformative technologies as a globally deployed universal platform for all product authenticity and supply chain track and trace requirements.”
1
1
